Medications
This
page
is
part
of
the
FHIR
Specification
(v4.3.0:
R4B
(v5.0.0-draft-final:
Final
QA
Preview
for
R5
-
STU
see
ballot
notes
).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Pharmacy Work Group | Maturity Level : N/A | Standards Status : Informative |
Compartments
:
|
Raw XML ( canonical form + also see XML Format Specification )
Intravenous Chemotherapy (Inpatient order) - Brentuximab Vedotin (id = "medadmin0305")
<?xml version="1.0" encoding="UTF-8"?> <MedicationAdministration xmlns="http://hl7.org/fhir"> <id value="medadmin0305"/>display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protoc ol_1Jun2017.pdfhttp://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protoc ol_1Jun2017.pdfdisplay: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%<text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: MedicationAdministration</b> <a name="medadmin0305"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationAdministration "medadmin0305" </p> </div> <p> <b> status</b> : completed</p> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a name="med0306"> </a> <blockquote> <p/> <p> <a name="med0306"> </a> </p> <p> <b> code</b> : Adcetris <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-ndc.html">National drug codes</a> #51144-050-01)</span> </p> <p> <b> marketingAuthorizationHolder</b> : <a href="organization-example-mmanu.html">Organization/mmanu</a> "Acme Corporation"</p> <p> <b> doseForm</b> : Lyophilized powder for injectable solution (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #421637006)</span> </p> <h3> Batches</h3> <table class="grid"><tr> <td> -</td> <td> <b> LotNumber</b> </td> <td> <b> ExpirationDate</b> </td> </tr> <tr> <td> *</td> <td> 12345</td> <td> 2019-10-31</td> </tr> </table> </blockquote> </td> </tr> </table> <p> <b> subject</b> : <a href="patient-example-a.html">Patient/pat1: Donald Duck</a> "Donald DUCK"</p> <p> <b> encounter</b> : <a href="encounter-example-f001-heart.html">Encounter/f001: encounter who leads to this prescription</a> </p> <p> <b> occurence</b> : 2015-01-15T04:30:00+01:00 --> 2015-01-15T14:30:00+01:00</p> <blockquote> <p> <b> performer</b> </p> <h3> Actors</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a href="practitioner-example-f007-sh.html">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</td> </tr> </table> </blockquote> <p> <b> request</b> : <a href="medicationrequest0316.html">MedicationRequest/medrx0316</a> </p> <h3> Dosages</h3> <table class="grid"><tr> <td> -</td> <td> <b> Text</b> </td> <td> <b> Route</b> </td> <td> <b> Dose</b> </td> <td> <b> Rate[x]</b> </td> </tr> <tr> <td> *</td> <td> 1.8 mg/kg IV infusion over 30 minutes</td> <td> Intravenous <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #255560000)</span> </td> <td> 1.8 mg/kg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg/kg = 'mg/kg')</span> </td> <td> 250 ml/30 min</td> </tr> </table> </div> </text> <contained> <Medication> <id value="med0306"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="51144-050-01"/> <display value="Adcetris"/> </coding> </code><marketingAuthorizationHolder> <reference value="Organization/mmanu"/> </marketingAuthorizationHolder> <doseForm> <coding> <system value="http://snomed.info/sct"/> <code value="421637006"/><display value="Lyophilized powder for injectable solution (qualifier value) "/> </coding> </doseForm> <batch> <lotNumber value="12345"/> <expirationDate value="2019-10-31"/> </batch> </Medication> </contained>http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protoc ol_1Jun2017.pdf<status value="completed"/><medication> <reference> <reference value="#med0306"/> </reference> </medication> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject><encounter> <reference value="Encounter/f001"/> <display value="encounter who leads to this prescription"/> </encounter> <occurencePeriod> <start value="2015-01-15T04:30:00+01:00"/> <end value="2015-01-15T14:30:00+01:00"/> </occurencePeriod> <performer> <actor><reference> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </reference> </actor> </performer> <request> <reference value="MedicationRequest/medrx0316"/> </request> <dosage> <text value="1.8 mg/kg IV infusion over 30 minutes"/> <route> <coding> <system value="http://snomed.info/sct"/> <code value="255560000"/> <display value="Intravenous"/> </coding> </route> <dose> <value value="1.8"/> <unit value="mg/kg"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </dose><rateRatio> <numerator> <value value="250"/> <unit value="ml"/> <system value="http://unitsofmeasure.org"/> </numerator> <denominator> <value value="30"/> <unit value="min"/> <system value="http://unitsofmeasure.org"/> </denominator> </rateRatio> </dosage> </ MedicationAdministration >
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR
®©
HL7.org
2011+.
FHIR
Release
4B
(v4.3.0)
hl7.fhir.r4b.core#4.3.0
R5
hl7.fhir.core#5.0.0-draft-final
generated
on
Sat,
May
28,
2022
12:56+1000.
Wed,
Mar
1,
2023
23:06+1100.
Links:
Search
|
Version
History
|
Table
of
Contents
|
Glossary
|
QA
Page
|
Compare
to
R4
R4B
|
Compare
to
R5
Draft
|
|
Propose
a
change